BRAFTOVI
Encorafenib
- Strength
- 75mg
- Manufacturer
- Pierre Fabre pharma
- Availability
- Available to source
Encorafenib 75mg — Capsule, 42's Strip
Need assistance?
Our multilingual healthcare support team can help with availability, shipping and ordering.
Chat on WhatsApp
Scan for WeChat
About this medicine
Originator: BRAFTOVI by ARRAY BIOPHARMA INC · Manufacturer: Pierre Fabre pharma. Indication & Dosage: BRAFTOVI (Encorafenib) is a prescription medicine used to treat of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, for adult patients with metastatic colorectal cancer (CRC) with a BRAF V600E mutation in combination with cetuximab, and for adult patients with metastatic non-small cell lung cancer (NSCLC). Encorafenib is not indicated for patients with wild-type BRAF melanoma, CRC, or NSCLC. BRAFTOVI manufactured by Pierre Fabre pharma Ltd. in France. Encorafenib has to take orally once a day with or without food as directed by patient’s doctor. Side Effects: The most common side effects of Encorafenib are: Nausea, vomiting, diarrhea, headache, tiredness, abdominal pain, joint pain or swelling, dry/itching skin, constipation, or dizziness. The above information comes from the Internet. Please consult with doctor for medical advice.
Indications
This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.
